AACR Annual Meeting 2021: Immunotherapy combination shows early promise in aggressive brain cancers 11 Apr 2021 Immunotherapy together with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers, promising early results from a Phase I trial presented at the 2021 AACR conference suggest. Find out more Show/Hide
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020 A personalised cancer vaccine, used in combination with an immunotherapy drug, triggers a response from the immune system that is specific to the cancer and shows some clinical benefit, according to the results of an early clinical trial presented at the virtual AACR conference. Find out more Show/Hide